Medicare’s GLP-1 Program Looms; Chemicals in Breast Milk; Acromegaly Drug Rejected
19/06/2026
Medicare’s GLP-1 Program A massive wave of new prescriptions for GLP-1 receptor agonists is expected following the July launch of
Aprobación de un nuevo parche de terapia hormonal genérico Recentemente, la FDA aprobó el primer genérico del sistema transdérmico de…
Read more →
Medicare’s GLP-1 Program A massive wave of new prescriptions for GLP-1 receptor agonists is expected following the July launch of
CHICAGO — Few men prescribed testosterone therapy received guideline-concordant diagnostic testing for androgen deficiency, and some received therapy despite contraindications,
The FDA cleared the first over-the-counter (OTC) integrated continuous glucose monitor (CGM) for children 2 years and older with or
CHICAGO — A multidisciplinary group of menopause experts developed new comorbidity-specific guidance on non-hormone therapy for moderate-to-severe vasomotor symptoms. First-Line
Resumen de la propuesta The Labor Department’s proposed rule to make it easier for employers to offer a fertility benefit